Search

Search Constraints

You searched for: Author/Creator Colafigli, Manuela

Search Results

1. A Comparison between two Dolutegravir-Based two-drug Regimens as Switch Strategies in a Multicentre Cohort of HIV-1-Infected Patients. Issue 1 (January 2019)

2. Anal cytological lesions and HPV infection in individuals at increased risk for anal cancer. Issue 7 (25th April 2018)

3. Anal Cytological Lesions and HPV Infection in Individuals at Increased Risk for Anal Cancer. Issue 7 (25th April 2018)

4. Atazanavir/ritonavir with lamivudine as maintenance therapy in virologically suppressed HIV-infected patients: 96 week outcomes of a randomized trial. (12th April 2018)

5. Baseline CD4+ T-cell Count and Cardiovascular Risk Factors Predict the Evolution of Cognitive Performance During 2-Year follow-up in HIV-Infected Patients. Issue 4 (May 2015)

6. Characterisation of HIV-1 molecular transmission clusters among newly diagnosed individuals infected with non-B subtypes in Italy. (10th May 2019)

7. Cohort profile: The Observational cohort for the study of DOlutegravir in Antiretroviral Combination REgimens (ODOACRE). Issue 12 (2nd December 2019)

8. Efficacy and durability of two‐ vs. three‐drug integrase inhibitor‐based regimens in virologically suppressed HIV‐infected patients: Data from real‐life ODOACRE cohort. Issue 9 (27th July 2021)

9. Genetic divergence of HIV-1 B subtype in Italy over the years 2003–2016 and impact on CTL escape prevalence. Issue 1 (December 2018)

10. Human papillomavirus detection in matched oral rinses, oropharyngeal and oral brushings of cancer-free high-risk individuals. (April 2019)